Stevens-Johnson syndrome associated with reduced tear production complicating the use of cetuximab and panitunumab

Int J Colorectal Dis. 2009 Oct;24(10):1247-8. doi: 10.1007/s00384-009-0676-4. Epub 2009 Feb 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Cetuximab
  • Female
  • Humans
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Middle Aged
  • Stevens-Johnson Syndrome / etiology*
  • Tears / metabolism*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • panitunumab
  • Cetuximab